COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,551 Articles (22,400 medRxiv, 8,151 bioRxiv)

Most recent first Previous |  Page 775: Articles 7741-7750  | Next

Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
Yu, X., Juraszek, J., Rutten, L., Bakkers, M. J. G., Blokland, S., van den Broek, N. J. F., Verwilligen, A. Y. W., Abeywickrema, P., Vingerhoets, J., Neefs, J.-M., Bakhash, S. A. M., Roychoudhury, P., Greninger, A., Sharma, S., Langedijk, J. P. M.
10.1101/2022.03.31.486561 — Posted: 2022-04-01
Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Planchais, C., Fernandez, I., Bruel, T., Dias de Melo, G., Prot, M., Beretta, M., Guardado-Calvo, P., Dufloo, J., Molinos-Albert, L. M., Backovic, M., Chiaravalli, J., Giraud, E., Vesin, B., Conquet, L., Grzelak, L., Planas, D., Staropoli, I., Guivel-Benhassine, F., Boulle, M., Cervantes-Gonzalez, M., French COVID Cohort Study Group, , CORSER Study Group, , Ungeheuer, M.-N., Charneau, P., van der Werf, S., Agou, F., Dimitrov, J. D., Simon-Loriere, E., Bourhy, H., Montagutelli, X., Rey, F. A., Schwartz, O., Mouquet, H.
10.1101/2022.04.01.486719 — Posted: 2022-04-01
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
Kaku, C. I., Bergeron, A. J., Ahlm, C., Normark, J., Sakharkar, M., Forsell, M. N., Walker, L. M.
10.1101/2022.04.01.486726 — Posted: 2022-04-01
Uptake of COVID-19 vaccines among pregnant women: a systematic review and meta-analysis
Galanis, P. A., Vraka, I., Siskou, O., Konstantakopoulou, O., Katsiroumpa, A., Kaitelidou, D.
10.1101/2022.04.01.22273296 — Posted: 2022-04-01
Long-term psychological consequences of long Covid: a propensity score matching analysis comparing trajectories of depression and anxiety symptoms before and after contracting long Covid vs short Covid
Fancourt, D., Steptoe, A., Bu, F.
10.1101/2022.04.01.22273305 — Posted: 2022-04-01
Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant
Ranzani, O. T., Hitchings, M., de Melo, R. L., de Franca, G. V. A., Fernandes, C. d. F. R., Lind, M., Torres, M. S. S., Tsuha, D. H., David, L. C. S., Said, R. F. C., Almiron, M., de Oliveira, R. D., Cummings, D. A. T., Dean, N. E., Andrews, J. R., Ko, A. I., Croda, J.
10.1101/2022.03.30.22273193 — Posted: 2022-04-01
If you build it, will they use it? Use of a Digital Assistant for Self-Reporting of COVID-19 Rapid Antigen Test Results during Large Nationwide Community Testing Initiative
Herbert, C., Shi, Q., Kheterpal, V., Nowak, C., Suvarna, T., Durnan, B., Schrader, S., Behar, S., Naeem, S., Tarrant, S., Kalibala, B., Singh, A., Gerber, B., Barton, B., Lin, H., Cohen-Wolkowiez, M., Corbie-Smith, G., Kibbe, W., Marquez, J., Baek, J., Hafer, N., Gibson, L., O'Connor, L., Broach, J., Heetderks, W., McManus, D., Soni, A.
10.1101/2022.03.31.22273242 — Posted: 2022-04-01
Metabolic alkalosis and mortality in COVID-19
Jiang, Z.
10.1101/2022.04.01.22273291 — Posted: 2022-04-01
Emulation of epidemics via Bluetooth-based virtual safe virus spread: experimental setup, software, and data
Asanjarani, A., Shausan, A., Chew, K., Graham, T., Short, K. R., Nazarathy, Y., Henderson, S. G., Jansen, H. M., Taylor, P. G., Vuorinen, A., Yadav, Y., Ziedins, I.
10.1101/2022.03.31.22273262 — Posted: 2022-04-01
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Banerjee, J., Friedman, J. M., Klesse, L. J., Yohay, K., Jordan, J. T., Plotkin, S., Allaway, R. J., Blakeley, J. O.
10.1101/2022.03.31.22273208 — Posted: 2022-04-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).